BioCryst Appoints New R&D Chief

BioCryst has appointed Sandeep M. Menon as its new Chief Research and Development Officer. Menon brings extensive experience in R&D leadership, with a proven history of advancing innovative therapies from early-stage development through global regulatory approval. His expertise is expected to significantly contribute to BioCryst's pipeline and strategic research initiatives. This appointment underscores the company's commitment to scientific innovation and drug development.